CSTL
Castle Biosciences Inc
35.80$
+1.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +128.1% | +434.5% | +266.9% | +5.3% | -3.3% | +1.3% | +17.2% | +8.9% | |
| – | +171.2% | +543.7% | +268.2% | -17.7% | -17.4% | +1.1% | +21.8% | +0.3% | |
| – | +269.5% | +2,107.1% | +314.6% | -19.6% | -62.7% | -19.6% | +21.1% | -2.5% | |
| – | +269.5% | +2,107.1% | +314.6% | -19.6% | -21.5% | -6.0% | +20.6% | +2.2% | |
| – | +159.9% | +21.2% | -12.9% | +35.4% | +35.8% | +63.2% | +33.7% | -15.3% | |
| – | +189.7% | +40.2% | +79.2% | -8.8% | +96.9% | +99.5% | +2.4% | +26.0% | |
| – | +4.0% | +34.7% | +244.8% | +137.7% | +56.9% | – | – | – | |
| – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | |
| – | -89.6% | – | – | – | +30.1% | -7.8% | -10.4% | -7.0% | |
| – | +34.8% | +6.6% | -31.8% | +115.1% | -5.2% | +28.8% | +21.5% | +42.8% | |
| – | +29.0% | +126.9% | +36.5% | +19.2% | +45.2% | +31.9% | +3.6% | +39.0% | |
| – | -100.0% | – | +0.0% | -79.8% | +50.7% | -36.0% | +70.9% | -10.3% | |
| – | +29.9% | +28.5% | +12.5% | +21.4% | +85.8% | +117.0% | -32.8% | +171.1% | |
| – | +39.2% | -21.3% | – | – | – | – | – | -1.1% | |
| – | – | – | +388.4% | -1.0% | -3.1% | -2.0% | +16.5% | +3.3% | |
| – | – | – | – | – | – | – | – | – | |
| – | +8.9% | -18.7% | +118.6% | +32.8% | +3.6% | +2.9% | +9.2% | -0.9% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.